Home Sign In About Curriculum Activity Information Target Audience Learning Objectives Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Novartis Oncology

Created in consultation with
Projects In Knowledge®, developers of certificate programs in medicine.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

Course materials have been developed for use outside of the United States.
banner

Slides  |   Abstract  |   Learning Objectives  |   Disclosure Information  |   Posttest  |   Technical Requirements

Update on Microcytic Anaemias


Diagnosing a microcytic anaemia is relatively straightforward; yet identifying the aetiology may prove difficult. In this webcast, Dr. Photis Beris and Dr. Achille Iolascon will discuss new forms of inherited and acquired microcytic anaemias, including DMT1 disease, Helicobacter pylori infection, and others. Join them to learn the pathophysiology, clinical picture, and diagnostic features of these lesser-known causes of iron-deficiency anaemias.
Faculty
Photis Beris, MD
Photis Beris, MD
Professor of Clinical
  Haematology
Department of Internal
  Medicine
Geneva University
  Hospital
Geneva, Switzerland
Achille Iolascon, MD, PhD
Achille Iolascon, MD, PhD
Medical Genetics Chair
University Federico II –
  Naples
CEINGE - Advanced
  Biotechnologies
Naples, Italy

Target Audience

This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.

Learning Objectives


After participating in this activity, participants should be better able to:
  • Assess the pathophysiology of microcytic anaemias due to iron metabolism defects and acquired conditions, and utilize established diagnostic methodologies in order to identify and diagnose patients with inherited or acquired iron-deficiency disease.
Disclosure Information

Photis Beris, MD, has received grant/research support from, is on the speakers bureau of, and is on the advisory board for Novartis Pharmaceuticals Corporation; and is a consultant for Vifor International.

Achille Iolascon, MD, PhD, has no significant relationships to disclose.

top

View Webcast

- requires Flash & high-speed Internet
(Tech. Requirements)


Download Slides

Ask the Experts   New!


 
ESH-Centre Hayem, Hôspital Saint-Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France - Contacts
All Rights Reserved - Copyright ESH 2010